Related Experiment Video
Updated: Jul 4, 2025

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
SGLT2 inhibition promotes glomerular repopulation by cells of renin lineage in experimental kidney disease
Loïs A K van der Pluijm1, Angela Koudijs1, Wendy Stam1
1Department of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Centre, Leiden, the Netherlands.
Aim:
Sodium glucose co-transporter-2 (SGLT2) inhibitors stimulate renal excretion of sodium and glucose and exert renal protective effects in patients with (non-)diabetic chronic kidney disease (CKD) and may as well protect against acute kidney injury (AKI). The mechanism behind this kidney protective effect remains unclear. Juxtaglomerular cells of renin lineage (CoRL) have been demonstrated to function as progenitors for multiple adult glomerular cell types in kidney disease. This study assesses the impact of SGLT2 inhibition on the repopulation of glomerular cells by CoRL and examines their phenotypic commitment.
Methods:
Experiments were performed in Ren1cre-tdTomato lineage-trace mice. Either 5/6 nephrectomy (5/6NX) modeling CKD or bilateral ischaemia reperfusion injury (bIRI) mimicking AKI was applied, while the SGLT2 inhibitor empagliflozin (10 mg/kg) was administered daily via oral gavage for 14 days.
Results:
Both 5/6NX and bIRI-induced kidney injury increased the number of glomerular CoRL-derived cells. SGLT2 inhibition improved kidney function after 5/6NX, indicated by decreased blood creatinine and urea levels, but not after bIRI. In line with this, empagliflozin in 5/6NX animals resulted in less glomerulosclerosis, while it did not affect histopathological features in bIRI. Treatment with empagliflozin resulted in an increase in the number of CoRL-derived glomerular cells in both 5/6NX and bIRI conditions. Interestingly, SGLT2 inhibition led to more CoRL-derived podocytes in 5/6NX animals, whereas empagliflozin-treated bIRI mice presented with increased levels of parietal epithelial and mesangial cells derived from CoRL.
Conclusion:
We conclude that SGLT2 inhibition by empagliflozin promotes CoRL-mediated glomerular repopulation with selective CoRL-derived cell types depending on the type of experimental kidney injury. These findings suggest a previously unidentified mechanism that could contribute to the renoprotective effect of SGLT2 inhibitors.
Insights
Sodium glucose co-transporter-2 (SGLT2) inhibitors promote kidney cell repopulation by juxtaglomerular cells of renin lineage (CoRL). This effect is selective, depending on the type of kidney injury, and may explain SGLT2 inhibitors' renoprotective benefits.
Area of Science:
- Nephrology
- Cell Biology
- Pharmacology
Background:
- Sodium glucose co-transporter-2 (SGLT2) inhibitors are known for renal protective effects in chronic kidney disease (CKD) and acute kidney injury (AKI).
- The precise mechanism underlying these renoprotective effects remains incompletely understood.
- Juxtaglomerular cells of renin lineage (CoRL) are identified as progenitor cells for various glomerular cell types in kidney disease.
Purpose of the Study:
- To investigate the impact of SGLT2 inhibition on glomerular cell repopulation by CoRL.
- To examine the phenotypic commitment of CoRL-derived cells under SGLT2 inhibition in different kidney injury models.
Main Methods:
- Experiments utilized Ren1cre-tdTomato lineage-trace mice subjected to 5/6 nephrectomy (5/6NX) for CKD or bilateral ischemia reperfusion injury (bIRI) for AKI.
- Mice received daily oral administration of the SGLT2 inhibitor empagliflozin (10 mg/kg) for 14 days.
- Changes in glomerular cell populations and kidney function were assessed.
Main Results:
- Both 5/6NX and bIRI increased glomerular CoRL-derived cells. SGLT2 inhibition improved kidney function and reduced glomerulosclerosis in 5/6NX models but not in bIRI models.
- Empagliflozin increased the number of CoRL-derived glomerular cells in both injury models.
- SGLT2 inhibition promoted CoRL-derived podocytes in 5/6NX and increased parietal epithelial and mesangial cells in bIRI models.
Conclusions:
- SGLT2 inhibition via empagliflozin enhances CoRL-mediated glomerular repopulation.
- The specific cell types repopulated by CoRL are dependent on the nature of the experimental kidney injury.
- These findings suggest a novel mechanism for the renoprotective action of SGLT2 inhibitors involving selective glomerular cell regeneration.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
Renal Drug Excretion: Glomerular Filtration
Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent arterioles....

